Antivirals shared are a problem eased in the fight against Covid-19

As the world struggles to find a way to live with Covid-19, the preliminary results of two antiviral drugs offer some hope.Molnupiravir, a drug developed by Merck and Ridgeback Biotherapeutics, and Paxlovid by Pfizer are both pending approval in the United States while Britain has already given the go-ahead to molnupiravir.The Merck-Ridgeback medication can cut death and hospitalisations by half while the Pfizer treatment does so by 89 per cent, according to the companies.It is still too early…

Stay connected with us on social media platform for instant update click here to join our T witter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Covid-19 News Click Here

Read original article here

Denial of responsibility! Rapidtelecast.com is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.